Our New Must-Read Journal
Population Health, Equity & Outcomes is our newest journal featuring content on health equity, population health, and improved outcomes.
Latest News
View All
Navigating the Complexities of Cancer Care: Cannabis and Cost Considerations
Miles Matter: The Geographic Disparity That Impacts Access to CAR T Therapy
Beyond Navigation: Thyme Care Ready for Heavy Lifts to Make Value-Based Care Work
Dr Maxine Dexter: Physician Voices are Crucial to Public Health
In Cancer Care, Innovation Comes at a Cost
Miles Matter: The Geographic Disparity That Impacts Access to CAR T Therapy
Delays in Myeloma Oral Therapy Linked to Race, Age
Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer
Addressing Barriers to Widespread Artificial Intelligence Adoption
Steady Premium Hikes Continue: Employer Health Costs Rise Another 7% in 2024
Research Explores Integration of Remote Monitoring for HF, Heart Transplant Allocation Impact
Dr Jonathan Kurman Outlines Emerging Bronchoscopic Therapies for COPD
Lung Cancer Experts Encourage Use of System-Based Interventions to Address Racial Disparities
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
mCRC Treatment Access: IRA Cost Cap Impact and Final Insights
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Complications of Uncontrolled Disease and Management of Comorbidities
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Care Coordination for High-Risk CRM Patients
Dr Maxine Dexter: Physician Voices are Crucial to Public Health
Role of Immunosuppressive Therapies in Managing ILD
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches
Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Standard of Care Durvalumab for Limited-Stage SCLC
Additional Immunotherapies on the Horizon for LS-SCLC
Navigating the Complexities of Cancer Care: Cannabis and Cost Considerations
In Cancer Care, Innovation Comes at a Cost
Miles Matter: The Geographic Disparity That Impacts Access to CAR T Therapy
Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer
Impact of Functional Recovery on Patients Having Heart Surgery
Patient Assignment and Quality Performance: A Misaligned System
Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs
Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries
COPD Treatment Ratio: A Measure for Improving COPD Population Health
Healthy State: Practicing What They Preach in Louisiana
AMCP Nexus 2024
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way
Navigating the Evolving Treatment Landscape of Metastatic Renal Cell Carcinoma
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
